The Protective Effect of Heat Shock Protein 72(HSP 72) on Hepatocyte in Rat Hepatic Warm Ischemia Reperfusion Injury

陈皓,邱伟华,邓侠兴,沈柏用,杨卫平,彭承宏,李宏为

2006-01-01

Abstract:Objective To study the protection of heat shock protein(HSP 72) induced by Sodium Arsenite(SA) for hepatic parenhymal cells in hepatic warm ischemia reperfusion injury in rat. Methods Partial hepatic warm ischemia-reperfusion model was used by clamping the blood flow to the left and median lobes. After 90 minutes of warm ischemia,the blood flow was restored. Blood and tissue sampling was collected at 3 and 6 hours after reperfusion. 24 hours before hepatic ischemia,SA was injected at a dose of 6 mg per kg body weight in SA group. Expression of HSP 72 and NF-κB was observed with Western blot; ALT,AST,LDH,TNF-α,CINC,MIP-2 were determined in peripheral blood; routine HE and immunohistochemical staining for HSP 72 NF-κB were examined. The survival rate of 7 days was observed. Results In 3-and 6-hour reperfusion after 90 minutes warm ischemia,significant expression of HSP 72 was observed in group SA but not in control group; in contrast,significant expression of NF-κB was observed in control group but not in group SA. Serum ALT,AST,LDH,TNF-α,CINC,MIP-2 also descended significantly in group SA compared with group NS(P0.05). Hepatic damage was alleviated notably in histological staining. Pathological study showed that ballooning,vacuolar denaturalization,coagulative necrosis in hepatocyte and neutrophilic infiltration were found in control group but not in SA group. Immunohistochemical study showed that HSP 72 was expressed sig-nificantly in both nucleus and cytoplasm of hepatocytes in SA group and was faint in control group. But NF-κB was markedly expressed in nucleus of hepatocytes in control group and was not in SA group. Conclusion These data suggested that the inducible expression of HSP 72 by SA may counteract hepatic warm ischemia reperfusion injury and may provide cytopretection for hepatocytes. HSP 72 can control the inflammatory reaction in hepatic warm ischemia reperfusion by preventing the activation of NF-κB.